1075178-40-3

Upstream product

• 3132-99-8 m-bromobenzoic aldehyde 
• 75-05-8 acetonitrile 
• 70591-86-5 3-(3-bromophenyl)-3-oxo-propanenitrile 
• 618-89-3 methyl 3-bromobenzoate 
• 585-76-2 m-bromobenzoic acid 
• 1075178-25-4 3-(3-bromophenyl)-3-hydroxypropanenitrile 

Downstream Products

• 1075178-41-4 N-(3-(3-bromophenyl)-3-hydroxypropyl)-2,2,2-trifluoroacetamide 
• 943321-68-4 (±)-tert-butyl N-(3-amino-3-phenyl-propyl)carbamate 
• 1098107-74-4 C₁₁H₉BrF₃NO₂ 
• 1098107-78-8 (R)-2,2,2-trifluoro-N-(3-hydroxy-3-(3-(3-hydroxy-3-propylhex-1-ynyl)phenyl)propyl)acetamide 
• 1098107-09-5 (±)-tert-butyl N-[3-(3-bromophenyl)-3-hydroxy-propyl]carbamate 
• 1075178-42-5 2,2,2-trifluoro-N-(3-hydroxy-3-phenylpropyl)acetamide 

Relevant academic research and scientific papers

Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopram

The utilization of fluorescent ligands to study the monoamine transporters (MATs) has increased our knowledge of their function and distribution in live cell systems. In this study, we extend SAR for nisoxetine and talopram as parent compounds, to identif

3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

AMINE DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

Provided are amine derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.

SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

Provided are sulphur-linked compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.

COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

Provided are compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.

ALKYNYL PHENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS

Provided are alkynyl phenyl derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.